ZO BILIMI
®
.
.
.
ZO Skin Health has developed a wide range of advanced skin care protocols and products. It includes therapeutic treatment protocols, highly effective products and daily skin care solutions that create and maintain healthy skin. Based on the latest scientific advances in skin treatment technologies, these products and protocols help physicians achieve sustained skin health for all skin types, genders and ages.
CURRENT STUDIES
At ZO® Skin Health, we believe that the only way to achieve skin health is the power of science. As our legacy, world-renowned dermatologist Dr. With Zein Obagi, ZO® Skin Health pushes the boundaries of medical-grade skincare. Combining our innovative approach, powerful technologies and product training, ZO® brings a new perspective to traditional skin care.
PRODUCT INNOVATIONS
.
.
.
At ZO Skin Health, we believe that the only way to achieve skin health is the power of science. Our legacy, world-renowned dermatologist Dr. With Zein Obagi, we push the boundaries of medical grade skincare by providing the best and most innovative products to create and maintain lifelong healthy skin for everyone, regardless of age, ethnicity, unique skin. condition or skin type.
Z0 TECHNOLOGIES
®
.
.
Our technological superiority lies in developing formulations that achieve superior results. These technologies are always multimodal, providing the most comprehensive approach to skincare, and are always paired with a delivery system that provides greater product penetration and precision. From skin-firming ZCORE™ to full skin defense Triple Spectrum Protection and a variety of retinol formulations, our technologies are both unique and effective.
RESEARCH AND DEVELOPMENT
.
.
Our Research + Development team focuses on finding unique ingredients that work synergistically to deliver the innovative products our doctors and patients deserve. Our team continues to deliver outstanding and patent-worthy results through a combination of industry relations, higher education partnerships + technical expertise.
.
.
